Last updated: 28 June 2024 at 7:35pm EST

Dr. Eric J. Patzer Net Worth




The estimated Net Worth of Eric Patzer is at least $885 dollars as of 24 June 2024. Dr Patzer owns over 714,286 units of Aridis Pharmaceuticals Inc stock worth over $885 and over the last 4 years he sold ARDS stock worth over $0.

Dr Patzer ARDS stock SEC Form 4 insiders trading

Dr has made over 3 trades of the Aridis Pharmaceuticals Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 714,286 units of ARDS stock worth $50,000 on 24 June 2024.

The largest trade he's ever made was buying 714,286 units of Aridis Pharmaceuticals Inc stock on 24 June 2024 worth over $50,000. On average, Dr trades about 146,292 units every 213 days since 2020. As of 24 June 2024 he still owns at least 884,600 units of Aridis Pharmaceuticals Inc stock.

You can see the complete history of Dr Patzer stock trades at the bottom of the page.





Dr. Eric J. Patzer biography

Dr. Eric J. Patzer is the Exec. Chairman at Aridis Pharmaceuticals Inc.



How old is Dr Patzer?

Dr Patzer is 71, he's been the Exec. Chairman of Aridis Pharmaceuticals Inc since . There are no older and 5 younger executives at Aridis Pharmaceuticals Inc.

What's Dr Patzer's mailing address?

Eric's mailing address filed with the SEC is C/O ARIDIS PHARMACEUTICALS, INC., 983 UNIVERSITY AVE, BLDG. B, LOS GATOS,, CA, 95032.

Insiders trading at Aridis Pharmaceuticals Inc

Over the last 6 years, insiders at Aridis Pharmaceuticals Inc have traded over $0 worth of Aridis Pharmaceuticals Inc stock and bought 1,445,847 units worth $181,502 . The most active insiders traders include Vu Truong, Eric Patzer a Fred Kurland. On average, Aridis Pharmaceuticals Inc executives and independent directors trade stock every 89 days with the average trade being worth of $125. The most recent stock trade was executed by Eric Patzer on 24 June 2024, trading 714,286 units of ARDS stock currently worth $50,000.



What does Aridis Pharmaceuticals Inc do?

aridis is a privately held infectious diseases focused company in san jose, ca, usa. aridis’ advanced formulation and delivery technologies are combined with proprietary products portfolio to create potent drug candidates that are packaged into convenient to administer, "ready-to-use" formats.



Complete history of Dr Patzer stock trades at Aridis Pharmaceuticals Inc

Človek
Trans.
Transakcia
Celková cena
Eric Patzer
Riaditeľ
Kúpa $50,000
24 Jun 2024
Eric Patzer
Riaditeľ
Využitie opcie $2,160
4 May 2023
Eric Patzer
Riaditeľ
Kúpa $25,047
27 Jul 2021


Aridis Pharmaceuticals Inc executives and stock owners

Aridis Pharmaceuticals Inc executives and other stock owners filed with the SEC include: